Bladder Cancer Clinical Trials in Rotterdam, South Holland
2 recruitingRotterdam, South Holland, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Non Muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC32 enrolled13 locationsNCT06637423
Recruiting
Phase 2
Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer
Bladder CancerSuperficial Bladder Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)49 enrolled3 locationsNCT03379909